logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Histamine-1 Receptor Antagonist class drugs

    FiltersReset Filters
    4 results

    • bepreve

      (bepotastine besilate)
      Bausch & Lomb Incorporated
      Usage: BEPREVE® (bepotastine besilate ophthalmic solution) 1.5% is indicated for treating itching linked to allergic conjunctivitis symptoms.

    • desloratadine

      (DESLORATADINE)
      Lupin Pharmaceuticals, Inc.
      Usage: Desloratadine tablets are indicated for relieving nasal and non-nasal symptoms of both seasonal and perennial allergic rhinitis in patients aged 12 years and older.

    • dymista

      (Azelastine Hydrochloride and Fluticasone Propionate)
      Meda Pharmaceuticals Inc.
      Usage: DYMISTA is indicated for the relief of symptoms of seasonal allergic rhinitis in adults and children aged 6 years and older.

    • quzyttir

      (Cetirizine Hydrochloride)
      TerSera Therapeutics LLC
      Usage: QUZYTTIR™ is indicated for the treatment of acute urticaria in adults and children aged 6 months and older. It is not recommended for pediatric patients under 6 years with impaired renal or hepatic function.